I hope that is not far off, or has it already happened?
The addressable market for Dermal Scaffolds is $1 Billion so “$2 Million per month” or $24 Million p.a. is only approx. 2.4% of the market.
Asprospective customers replace old inventories and we gain new customers at thesame pace as they have increased sales staff sales revenue growth couldcontinue to “double and double again”, to borrow a phrase.
Iunderstand our product can become the industry standard so 2.4%, of themarket means we are still at a very early stage.
Ihope it will not be long before we achieve 10 times “$2 Million per month”,or 24% of the addressable market – because that means 76% of patientsare not yet getting the best available treatment! IMO, DYOR etc.
- Forums
- ASX - By Stock
- PNV
- Ann: PolyNovo presents in New York
Ann: PolyNovo presents in New York, page-33
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.43 |
Change
-0.040(1.62%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$2.48 | $2.51 | $2.43 | $1.692M | 690.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 19941 | $2.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.45 | 4032 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 19941 | 2.430 |
1 | 6170 | 2.420 |
8 | 35200 | 2.410 |
7 | 9242 | 2.400 |
6 | 27475 | 2.390 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 4032 | 3 |
2.460 | 10716 | 5 |
2.470 | 8108 | 2 |
2.480 | 11160 | 4 |
2.490 | 14138 | 3 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online